Trinity Biotech publishes 2025 annual report - TRIB News | RalliesTrinity Biotech publishes 2025 annual report
T
TRIB• Annual report outlines priorities and risks
- Trinity Biotech published its 2025 annual report, outlining business priorities amid an evolving diagnostics market.
- Report highlights product development and commercialization plans, including potential strategic partnerships to expand market reach.
- Management flagged ongoing competitive pressure, capital needs, and execution risks tied to operations and new product initiatives.
- Board changes included Paul Murphy’s appointment on Aug. 6, 2025, following retirements and resignations during 2025-2026.
META
•
